Verrica Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-7.0M | $8.7M |
| FY2018 | — | $89.4M | $10.3M |
| FY2019 | — | $65.0M | $9.2M |
| FY2020 | — | $33.0M | $10.7M |
| FY2021 | — | $32.6M | $15.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-7.0M | $8.7M |
| FY2018 | — | $89.4M | $10.3M |
| FY2019 | — | $65.0M | $9.2M |
| FY2020 | — | $33.0M | $10.7M |
| FY2021 | — | $32.6M | $15.8M |